N Jourdan
Overview
Explore the profile of N Jourdan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sargison N, Mazeri S, Gamble L, Lohr F, Chikungwa P, Chulu J, et al.
Prev Vet Med
. 2020 Dec;
186:105225.
PMID: 33348303
The world's growing population is becoming increasingly centred around large cities, affording opportunities for peri-urban food production. Goats are well-suited to conversion of resources that are available in peri-urban settings...
2.
Descotes G, Moine M, Beau F, Noyer V, Nicoulaud J, Divanon F, et al.
Ann Pharm Fr
. 2020 Apr;
78(4):324-334.
PMID: 32247514
Objective: Describe the process for designing and creating SimUPAC 360°, a virtual reality training in anti-cancer drug production units. Methods: A multi-centre (a University Hospital, a General Hospital and a...
3.
Moine M, Clou E, Bonsergent M, Sankhare D, Madelaine I, Jourdan N
Ann Pharm Fr
. 2019 May;
77(4):324-333.
PMID: 31138436
Objectives: Within the context of pharmacy technician's (PT) continuing training (CT), a theoretical instruction in onco-hematology has been developed for PT working in our cytotoxic preparation unit (CPU). The aim...
4.
Chouquet T, Acramel A, Sauvageon H, Ple A, Jourdan N, Madelaine I, et al.
Ecotoxicol Environ Saf
. 2018 Sep;
165:174-181.
PMID: 30195999
Introduction: Cytotoxic drug exposure of hospital staff preparing intravenous chemotherapy is a major issue and related mutagenic risks should be more explored. The aim of this study was to assess...
5.
[Implementation and assessment of anticancer drugs batch preparation circuit in a teaching hospital]
Moine M, Hachon L, Sankhare D, Ade A, Madelaine I, Jourdan N
Ann Pharm Fr
. 2018 Apr;
76(4):306-320.
PMID: 29625693
Introduction: In 2011, the anticancer preparation unit in a teaching hospital implemented a circuit for batch preparation of anticancer drugs. In this circuit, a manual and a semi-automatic production process...
6.
Dunyach-Remy C, Courtais-Coulon C, Demattei C, Jourdan N, Schuldiner S, Sultan A, et al.
Diabetes Metab
. 2016 Oct;
43(2):167-171.
PMID: 27720361
Aims: Nasal carriage of Staphylococcus aureus in diabetic patients may be a risk factor for diabetic foot lesion infections. The aims of this study were to compare the genotypic profiles...
7.
Sotto A, Richard J, Combescure C, Jourdan N, Schuldiner S, Bouziges N, et al.
Diabetologia
. 2010 Jun;
53(10):2249-55.
PMID: 20571753
Aims/hypothesis: In 2003, guidelines for management of diabetic foot infection (DFI) were written by the authors' team according to the guidelines of the International Working Group on the Diabetic Foot....
8.
Sotto A, Laouini D, Bouziges N, Jourdan N, Richard J, Lavigne J
Pathol Biol (Paris)
. 2009 Oct;
58(1):73-7.
PMID: 19875242
Purpose Of The Study: The aim of this study was to evaluate the in vitro activity of daptomycin and other comparator agents against bacterial strains isolated from diabetic foot infections...
9.
Jourdan N, Le Hello S, Delmas G, Clouzeau J, Manteau C, Desaubliaux B, et al.
Euro Surveill
. 2008 Sep;
13(39).
PMID: 18822245
No abstract available.
10.
Richard J, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, et al.
Diabetes Metab
. 2008 Jul;
34(4 Pt 1):363-9.
PMID: 18632297
Aim: To determine the risk factors for acquiring multidrug-resistant organisms (MDRO) and their impact on outcome in infected diabetic foot ulcers. Methods: Patients hospitalized in our diabetic foot unit for...